Editorial

Abstract

Although the field of lung transplantation (LT) has evolved significantly in the past decades, there is an urgent need for the development of more effective strategies to improve graft and patient outcomes. The median 6.7-year post-transplant survival represents one of the lowest among solid organs and is limited primarily by allograft failure due to chronic lung allograft rejection (CLAD).